BTG is an international specialty pharmaceuticals company. They just announced the start of trials on a product in the US to treat varicose veins. Morrison Vein Institute is a principal investigator in this new study. Dr Nick Morrison and Barbara Deusterman, RN of Morrison Vein Institute just got back from the BTG meeting in Florida and are starting the setup for this trial in our Scottsdale office. People from all over the country will participate in this BTG study. This is a huge deal for Morrison Vein Institute.
Published by morrisonvein
Morrison Vein Institute is a medical practice that specializes in the treatment of Varicose and Spider Veins. The Morrison Vein Institute takes the most advanced treatments of veins and vein disease available today and makes them even better by providing compassionate and thorough care. The Morrison Vein Institute specializes in minimally invasive, outpatient procedures for varicose and spider veins, such as Sclerotherapy, Ambulatory Phlebectomy, Endovenous Laser Ablation, VNUS Closure, and Ultrasound-Guided Sclerotherapy, and cosmetic spider vein treatments. Nick Morrison, MD, FACPh, FACS, RPhS, President, International Union of Phlebology, Member, American College of Phlebology Foundation Board Past President, American College of Phlebology, Medical Director. Our team has dedicated our medical practice to veins for 20 years. We are joined in practice by James McEown, MD, Karen Garby, MD and our expert Morrison Vein schedulers, ambassadors and the Professional RN Dream Team. View all posts by morrisonvein